Annual RNA Targeted Drug Discovery & Development Summit

The Annual RNA Targeted Drug Discovery & Development Summit is a premier event dedicated to advancing the field of RNA-targeted small molecules, set to take place at the Hotel Commonwealth in Boston. This summit, recognized as the industry's only dedicated forum for RNA-targeted therapeutics, aims to accelerate the discovery and translation of RNA-targeted small molecules, which are crucial for developing improved treatments for oncological, rare genetic, and neurodegenerative conditions.

The event will gather leaders from pioneering biotech firms, major pharmaceutical companies, and academia to discuss the latest advancements, practical strategies, and collaborative initiatives shaping the future of RNA-based therapeutics.

Attendees can expect a comprehensive agenda featuring over 80 experts in RNA-targeted small molecules, including 18 expert-led case studies that delve into RNA target discovery, chemistry, optimization, validation, and translation. There will be three interactive workshops focused on functional RNA target selection, RNA structure probing, and RNA-focused chemical space.

Additionally, dedicated discussions will address critical topics such as selecting the right screening strategies and building RNA-focused libraries. The summit is an invaluable opportunity to explore new data across various domains, including splice modulation, direct RNA binding, fragment discovery, covalent translation inhibition, and kinetic characterization.

This gathering serves as a platform for exchanging insights and fostering collaborations among thought leaders in the RNA-centric drug discovery community, ensuring a rich environment for networking and the sharing of innovative ideas.